drugset / Trial / NCT00551148
A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to further explore an effective dose range of PD0200390 for the treatment of patients with insomnia.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATAGABALIN | Small molecule | 5 mg | Oral |
| Subject | ATAGABALIN | Small molecule | 15 mg | Oral |
| Subject | ATAGABALIN | Small molecule | 30 mg | Oral |
| Subject | ATAGABALIN | Small molecule | 60 mg | Oral |